Molecular and clinicopathological markers of prognosis in breast cancer

Author： Boyle David P McCourt Clare M Matchett Kyle B Salto-Tellez Manuel

ISSN： 1473-7159

Source： Expert Review of Molecular Diagnostics, Vol.13, Iss.5, 2013-06, pp. : 481-498

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeted Pathways in Breast Cancer: Molecular and Protein Markers Guiding Therapeutic Decisions

Current Molecular Pharmacology, Vol. 7, Iss. 1, 2014-04 ,pp. : 4-21

Bentham Science Publishers

Access to resources Recommend Favorite

Clinicopathological Significance of Mesothelin Expression in Invasive Breast Cancer

By Wang L Niu Z Zhang L Liu X Wang X Li F Wang Y

The Journal of International Medical Research, Vol. 40, Iss. 3, 2012-05 ,pp. : 909-916

Field House Publishing

Access to resources Recommend Favorite

Molecular Chemotherapy for Breast Cancer

By Patterson A.

Drugs & Aging, Vol. 14, Iss. 2, 1999-02 ,pp. : 75-90

Adis International

Access to resources Recommend Favorite

Genomics-Based Prognosis and Therapeutic Prediction in Breast Cancer

By Jeffrey Stefanie S. Lønning Per Eystein Hillner Bruce E.

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 3, Iss. 3, 2005-05 ,pp. : 291-300

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Molecular Targeting of Breast Cancer: Molecular Imaging and Therapy

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 4, 2011-01 ,pp. : 528-538

Bentham Science Publishers

Access to resources Recommend Favorite